According to Hikma Pharmaceuticals
's latest financial reports the company's current revenue (TTM ) is $2.87 Billion USD. In 2023 the company made a revenue of $2.87 Billion USD an increase over the revenue in the year 2022 that were of $2.51 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 | $2.87 B | 14.22% |
2022 | $2.51 B | -1.41% |
2021 | $2.55 B | 9.06% |
2020 | $2.34 B | 6.07% |
2019 | $2.20 B | 6.62% |
2018 | $2.07 B | 6.92% |
2017 | $1.93 B | -0.72% |
2016 | $1.95 B | 35.42% |
2015 | $1.44 B | -3.29% |
2014 | $1.48 B | 9.08% |
2013 | $1.36 B | 23.08% |
2012 | $1.10 B | 20.8% |
2011 | $0.91 B | 25.6% |
2010 | $0.73 B | 14.77% |
2009 | $0.63 B | 9.68% |
2008 | $0.58 B | 29.38% |
2007 | $0.44 B | 41.57% |
2006 | $0.31 B | 20.9% |
2005 | $0.26 B | 23.47% |
2004 | $0.21 B | 101.98% |
2003 | $0.10 B | 22.98% |
2002 | $85.5 M |